Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

NCT04980378 — Completed, 291 participants, NuVasive

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT04980378
StatusCompleted
Study typeObservational
Enrollment291 (Actual)
SponsorNuVasive (Industry)
ConditionsCervical Degenerative Disc Disorder
InterventionsSimplify Disc (Device)
Datesstart 2021-08-01, primary completion 2024-01-24, completion 2024-01-24, first posted 2021-07-28, last updated 2026-01-08
Locations18 sites in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Cervical Degenerative Disc Disorder All trials of Simplify Disc

-Summary

This study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized two-level Simplify Disc Investigational Device Exemption (IDE) study. This study was conducted under IDE G150206

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Simplify DiscDevice: Simplify DiscExtended follow-up of IDE Subjects treated at two continuous levels with the Simplify Cervical Artificial Disc during IDE G150206
Historical Control - Anterior Cervical Discectomy and Fusion (ACDF)This study used a non-concurrent historical control with subject-level data on a parallel group design. The historical control group was formed from the randomized ACDF arm of a previously completed two level cervical disc trial.
  • Simplify Disc (Device): The Simplify Disc is a cervical artificial disc manufactured from polyether ether ketone (PEEK) endplates and a mobile, zirconia-toughened alumina ceramic core.

+Outcome measures

Primary outcomes

  • Clinical Composite Success [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: Individual success for Simplify Disc was defined as follows: * Neck Disability Index (NDI) score improvement of at least 15 points from pre-operative; * Maintenance or improvement in neurological status; * No serious adverse event classified as implant associated or implant/surgical procedure associated; and * No additional surgical procedure classified as a "failure."

Secondary outcomes

  • Clinically Significant Improvement in One or More Radicular Symptoms or Myelopathy [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: An arm pain questionnaire was used to measure radicular symptoms and compare to baseline symptoms in the IDE study. Changes of at least 2 points on a 10-point scale were regarded as clinically significant (0=no pain; 10=worst pain)
  • Health Survey; 36-Item Short Form Survey (SF-36) - Physical Component Score (PCS) Maintenance or Improvement [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: The PCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as PCS(Postop) - PCS(Preop) ≥0.
  • Health Survey; 36-Item Short Form Survey (SF-36) - Mental Component Score (MCS) Maintenance or Improvement [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: The MCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as PCS(Postop) - PCS(Preop) ≥0.
  • Dysphagia Handicap Index (DHI Scale) [Data through 24 months gathered in IDE (NCT03123549 with start date of 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-operative.]: Dysphagia Handicap Index score for the Simplify Disc subjects at 60 months. A higher score is indicative of a less desirable outcome. It is scored 0-100. Data was not collected on DHI in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
  • Patient Satisfaction [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: Patient satisfaction was assessed by survey based on the response to the statement "I am satisfied with the results of my surgery" at 60 months. Answer options ranged from definitely true to definitely false.
  • Physician's Perception [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: Results at 60 months were categorized by the physician's perception of the subject's condition (excellent, good, fair, or poor).
  • Change in Average Disc Height (Superior Index Level) [Data through 24 months gathered in IDE (NCT03123549 with start date of 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-operative.]: Average disc height (superior index level) at 60 months was compared to the baseline measurement in the IDE study and the change was calculated. Measurements were scored by an independent core lab. Average disc height was calculated as the simple average of the anterior and posterior disc heights. Data was not collected on average disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
  • Change in Average Disc Height (Inferior Index Level) [Data through 24 months gathered in IDE (NCT03123549 with start date of 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-operative.]: Average disc height (inferior index level) at 60 months was compared to the baseline measurement in the IDE study and the change was calculated. Measurements were scored by an independent core lab. Average disc height was calculated as the simple average of the anterior and posterior disc heights. Data was not collected on average disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
  • Adjacent Level Deterioration - Superior Adjacent Level [Data through 24 months gathered in IDE (NCT03123549 with start date of 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-operative.]: Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) above the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), or severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space). Assessments were made by an independent core lab. Data was not collected on adjacent level deterioration in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
  • Adjacent Level Deterioration - Inferior Adjacent Level [Data through 24 months gathered in IDE (NCT03123549 with start date of 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-operative.]: Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) below the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), or severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space). Assessments were made by an independent core lab. Data was not collected on adjacent level deterioration in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
  • Displacement or Migration of the Device [Data through 24 months gathered in IDE (NCT03123549; start date 4/1/17). This PAS (start date 8/1/21) followed the same patient cohort through 60 months post-op. Comparison data from historical controls up to 60 months post-op is also reported]: Displacement or migration of the device at 60 months was be compared to immediate post-op data collected in the IDE study. This was be graded by the radiographic core lab. Migration was considered "present" if changes of >3mm were noted. The superior index level and inferior index level was assessed separately.

+Eligibility

Sex: All

Inclusion Criteria:

\- All subjects enrolled in the two level Simplify Disc IDE study are considered for this long-term follow-up study.

Exclusion Criteria:

* Subjects who were not implanted with the Simplify Disc during the IDE study
* Subjects who had a secondary surgical intervention at the index level during the IDE study
* Subjects who were withdrawn or withdrew consent to participate in the IDE study
* Subjects who do not consent to participate in long-term follow-up post-approval study

+Posted results

Participant flow

MilestoneSimplify DiscHistorical ACDF Control
Started157134
Completed144107
Not completed1327

Outcome results

  • Clinical Composite Success (Primary), Count of participants, Participants: Simplify Disc 127; ACDF: Historical ACDF control data 84
  • Clinically Significant Improvement in One or More Radicular Symptoms or Myelopathy (Secondary), Count of participants, Participants: Simplify Disc 125; ACDF: Historical ACDF control data 90
  • Health Survey; 36-Item Short Form Survey (SF-36) - Physical Component Score (PCS) Maintenance or Improvement (Secondary), Count of participants, Participants: Simplify Disc 122; ACDF: Historical ACDF control data 86
  • Health Survey; 36-Item Short Form Survey (SF-36) - Mental Component Score (MCS) Maintenance or Improvement (Secondary), Count of participants, Participants: Simplify Disc 110; ACDF: Historical ACDF control data 80
  • Dysphagia Handicap Index (DHI Scale) (Secondary), Mean, score on a scale: Simplify Disc 7.1 +/- 11.6
  • Patient Satisfaction (Secondary), Count of participants, Participants: Simplify Disc 116; ACDF: Historical ACDF control data 77
  • Physician's Perception (Secondary), Count of participants, Participants: Simplify Disc 126; ACDF: Historical ACDF control data 57
  • Change in Average Disc Height (Superior Index Level) (Secondary), Mean, mm: Simplify Disc 1.10 +/- 0.84
  • Change in Average Disc Height (Inferior Index Level) (Secondary), Mean, mm: Simplify Disc 0.81 +/- 0.94
  • Adjacent Level Deterioration - Superior Adjacent Level (Secondary), Count of participants, Participants: Simplify Disc 70
  • Adjacent Level Deterioration - Inferior Adjacent Level (Secondary), Count of participants, Participants: Simplify Disc 81
  • Displacement or Migration of the Device (Secondary), Count of participants, Participants: Simplify Disc 0; ACDF: Historical ACDF control data 0

Adverse events

Time frame: Data presented includes adverse events (AEs) collected under both the parent IDE study (G150206) and this Post Approval Study (PAS) for patients who enrolled in this PAS. Data collected from the time of surgery through 24 months was gathered in the IDE (NCT03123549; start date 4/1/17) and data for the same patient cohort from 24 months through 60 months post-op was gather under this PAS (start date 8/1/21). Comparison data from historical controls through 60 months post-op is also reported

ArmDeathsSerious adverse eventsOther adverse events
Simplify Disc0/157 (0.0%)40/157 (25.5%)119/157 (75.8%)
ACDF: Historical ACDF Control Data0/134 (0.0%)54/134 (40.3%)126/134 (94.0%)

Serious adverse events by term

TermOrgan systemSimplify DiscACDF: Historical ACDF Control Data
Lumbar radiculopathyMusculoskeletal and connective tissue disorders13/15714/134
Infection (not at surgical site)Infections and infestations7/1572/134
Appendicular arthritisMusculoskeletal and connective tissue disorders3/1576/134
CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)3/1573/134
OtherGeneral disorders2/1574/134
Low back painMusculoskeletal and connective tissue disorders1/1575/134
DysphagiaGastrointestinal disorders2/1573/134
Accidental traumaGeneral disorders3/1572/134
Gastrointestinal complicationsGastrointestinal disorders2/1572/134
Cervical radiculopathyMusculoskeletal and connective tissue disorders3/1571/134
Pain (no narcotic given)General disorders2/1571/134
Hematoma or seromaVascular disorders2/1570/134
StrokeVascular disorders2/1570/134
Difficulty with urinationRenal and urinary disorders1/1571/134
EmbolismVascular disorders1/1571/134
InflammationGeneral disorders1/1571/134
Blood loss (greater than 500 mL)Injury, poisoning and procedural complications1/1570/134
Spinal stenosisMusculoskeletal and connective tissue disorders1/1570/134
Vertebral fractureMusculoskeletal and connective tissue disorders1/1570/134
HypertensionVascular disorders1/1570/134
ThromboembolismVascular disorders1/1570/134
Nonunion/pseudoarthrosisMusculoskeletal and connective tissue disorders0/1575/134
Psychological illnessPsychiatric disorders0/1573/134
Development of DDD at adjacent levelsMusculoskeletal and connective tissue disorders0/1572/134
Surgery at a location other than the spineSurgical and medical procedures0/1572/134
Cerebrospinal fluid leakageNervous system disorders0/1571/134
Coordination abnormalitiesGeneral disorders0/1571/134
HeadacheGeneral disorders0/1571/134
PneumoniaInfections and infestations0/1571/134
Pulmonary embolismVascular disorders0/1571/134
ThrombosisVascular disorders0/1571/134
Surgery at another spine levelSurgical and medical procedures0/1571/134
Cardiac eventCardiac disorders0/1571/134
AtelectasisRespiratory, thoracic and mediastinal disorders0/1571/134
Soft tissue damageMusculoskeletal and connective tissue disorders0/1571/134
Dermatitis/Skin allergySkin and subcutaneous tissue disorders0/1571/134
Low back pain (narcotic given)Musculoskeletal and connective tissue disorders0/1571/134
Sleep apneaRespiratory, thoracic and mediastinal disorders0/1571/134
Renal dysfunctionRenal and urinary disorders0/1571/134

Other adverse events by term

TermOrgan systemSimplify DiscACDF: Historical ACDF Control Data
Pain (no narcotic given)General disorders32/15737/134
Accidental traumaGeneral disorders27/15739/134
InflammationGeneral disorders30/15729/134
Cervical radiculopathyMusculoskeletal and connective tissue disorders29/15729/134
Lumbar radiculopathyMusculoskeletal and connective tissue disorders30/15728/134
Appendicular arthritisMusculoskeletal and connective tissue disorders11/15732/134
Infection (not at surgical site)Infections and infestations22/15718/134
Compressive neuropathyNervous system disorders18/15720/134
HeadacheGeneral disorders8/15723/134
OtherGeneral disorders11/15719/134
Low back pain (no narcotic given)Musculoskeletal and connective tissue disorders10/15712/134
Pain (narcotic given)General disorders8/15711/134
Gastrointestinal complicationsGastrointestinal disorders6/15721/134
Development of DDD at adjacent levelsMusculoskeletal and connective tissue disorders1/15713/134
Low back pain (narcotic given)Musculoskeletal and connective tissue disorders1/15713/134
Non-Infectious pulmonary disorderRespiratory, thoracic and mediastinal disorders0/15712/134
Numbness - increased from pre-op or prior visitNervous system disorders5/15711/134
SpasmMusculoskeletal and connective tissue disorders2/15711/134
DysphagiaGastrointestinal disorders7/1579/134
Cardiac eventCardiac disorders4/1579/134
Neck stiffnessMusculoskeletal and connective tissue disorders1/1579/134
Psychological illnessPsychiatric disorders3/1578/134
HypertensionVascular disorders2/1578/134
Dermatitis/Skin allergySkin and subcutaneous tissue disorders2/1578/134
Nonunion/pseudoarthrosisMusculoskeletal and connective tissue disorders1/1577/134
Sleep apneaRespiratory, thoracic and mediastinal disorders0/1577/134
Allergic rhinitisImmune system disorders0/1577/134

+Locations (18)

FacilityCityCountryStatus
Orthopaedic Education and Research Institute of Southern CaliforniaOrange, CaliforniaUnited States
The Spine Institute for Spine RestorationSanta Monica, CaliforniaUnited States
Spine Education and Research FoundationThornton, ColoradoUnited States
Connecticut Orthopaedic SpecialistsHamden, ConnecticutUnited States
Kennedy-White Orthopedic CenterSarasota, FloridaUnited States
NorthShore University Health SystemEvanston, IllinoisUnited States
Indiana Spine GroupCarmel, IndianaUnited States
Parkview Research CenterFort Wayne, IndianaUnited States
Orthopaedic Institute of Western KentuckyPaducah, KentuckyUnited States
Spine Institute of LouisianaShreveport, LouisianaUnited States
William Beaumont Hospital Research InstituteRoyal Oak, MichiganUnited States
Buffalo Spine SurgeryLockport, New YorkUnited States
Carolina Neurosurgery and Spine AssociatesCharlotte, North CarolinaUnited States
Oregon NeurosurgerySpringfield, OregonUnited States
Texas Spine ConsultantsAddison, TexasUnited States
Texas Back InstitutePlano, TexasUnited States
The Disc Replacement CenterWest Jordan, UtahUnited States
Virginia Spine InstituteReston, VirginiaUnited States

+Study documents

+Investigators